Services
Expertise
People
News
Resources
Careers
Contact

Publications

April 2025

Translational PK/PD Modelling of MEK inhibitors: Trametinib, Cobimetinib and Binimetinib

Seda Author(s) J. Dickinson

Date: April 2025

Published: AACR Chicago 2025

Categories

Research Papers and Book Chapters
Posters and Abstracts
Other

Recent

May 2025
November 2024
June 2024
January 2024
November 2023
April 2023
March 2023
November 2022
September 2022
August 2022
May 2022
February 2022
November 2021
September 2021
January 2021

Archive

2025
2024
2023
2022
2021

About SEDA

Seda Pharmaceutical Development Services provide Pharmaceutical Development and Clinical Pharmacology services and consultancy to the Pharma and Biotechnology Industry. We enable the rapid and efficient development of optimal medicinal products by providing coherent and synergistic support.

Get in touch

Seda Pharmaceutical Development Services
Unit 4 Oakfield Road
Cheadle Royal Business Park
Cheadle
Stockport
Greater Manchester
SK8 3GX

E: enquiries@sedapds.com

Follow us

Home
Services
Expertise

Seda Pharmaceutical Development Services® is the business name and registered trademark of Seda Pharma Development Services Ltd, a company incorporated in England and Wales with registered number: 9442533 and registered office: Unit 4 Oakfield Road, Cheadle Royal Business Park, Cheadle, Stockport, Greater Manchester, England, SK8 3GX.

© Copyright 2015-2025 Seda Pharmaceutical Development Services® | Privacy Notice | Sitemap

Site design by CREATIVE PITCH®